10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (TXG)

Q: What does CUSIP 88025U109 represent in this 13F holders report?

CUSIP 88025U109 is the security identifier for TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share used to aggregate holder disclosures.

Q: How many institutions held TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share in Q3 2023?

252 institutional investors reported TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share for Q3 2023. Use the holders table for investor-level position and value details.

CUSIP: 88025U109

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / Class A Common Stock, $0.00001 par value per share
Total 13F shares: 90,883,461
Total 13F value: $3,748,861,587
Share change: +1,969,693
Put/Call ratio: 48%
SEC-reported price per share: $41.25
Number of holders: 252
Value change: +$66,054,684
Number of buys: 111
Number of sells: 146
Shares outstanding: 116,858,154

Security key

88025U109

Report period

Q3 2023

Institutions

252

Top holders

TXG full security history Ownership snapshot Full 13F holder table 10x Genomics, Inc. SEC filings 10x Genomics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

15/15

Latest evidence

30 Jun 2023

13F Lead comparable stake: 7.3% Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 7.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Comparable ownership Top 5

VANGUARD GROUP INC 7.3%

BAILLIE GIFFORD & CO 7.3%

FMR LLC 6.9%

MORGAN STANLEY 4.8%

BlackRock Finance, Inc. 4.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	7.3%	$477,353,601 8,548,596 shares	—	30 Jun 2023
BAILLIE GIFFORD & CO	13F Company 13F	7.3%	$474,877,153 8,504,247 shares	—	30 Jun 2023
FMR LLC	13F Company 13F	6.9%	$452,393,223 8,101,598 shares	—	30 Jun 2023
MORGAN STANLEY	13F Company 13F	4.8%	$315,389,154 5,648,085 shares	—	30 Jun 2023
BlackRock Finance, Inc.	13F Company 13F	4.6%	$301,701,063 5,402,956 shares	—	30 Jun 2023
SANDS CAPITAL MANAGEMENT, LLC	13F Company 13F	3.5%	$230,075,821 4,120,269 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

252

90,883,461

Rows available

252

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

269

Q3 2023 holders

252

Holder diff

-17

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %